The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Short Acting Nicotine Replacement Therapy Market Research Report 2025
Synopsis
The global market for Short Acting Nicotine Replacement Therapy was valued at US$ 1725 million in the year 2024 and is projected to reach a revised size of US$ 2411 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Short-acting Nicotine Replacement Therapy (NRT) refers to fast-acting products that deliver nicotine quickly to help manage sudden cravings and withdrawal symptoms during smoking cessation. These include nicotine gum, lozenges, nasal sprays, and oral inhalers, which allow users to control their nicotine intake in real time. Unlike long-acting options like nicotine patches, short-acting NRT provides rapid relief and can be used as needed, making it effective for managing acute urges and improving quit success when combined with behavioral support.
North American market for Short Acting Nicotine Replacement Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Short Acting Nicotine Replacement Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Short Acting Nicotine Replacement Therapy in Online Sales is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Short Acting Nicotine Replacement Therapy include Nicorette (Johnson & Johnson), Dr. Reddy's Laboratories, Equate (Walmart), Swedish Match, NiQuitin (Perrigo), Altria, Philip Morris, Alkalon, LUCY GOODS, Nicotex (Cipla Health), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Short Acting Nicotine Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Acting Nicotine Replacement Therapy.
The Short Acting Nicotine Replacement Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Acting Nicotine Replacement Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Acting Nicotine Replacement Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nicorette (Johnson & Johnson)
Dr. Reddy's Laboratories
Equate (Walmart)
Swedish Match
NiQuitin (Perrigo)
Altria
Philip Morris
Alkalon
LUCY GOODS
Nicotex (Cipla Health)
Japan Tobacco International (JTI)
British American Tobacco (BAT)
Skruf Snus
Segment by Type
Nicotine Gum
Nicotine Lozenge
Nasal Spray
Oral Inhaler
Nicotine Pouches
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Short Acting Nicotine Replacement Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Short Acting Nicotine Replacement Therapy was valued at US$ 1725 million in the year 2024 and is projected to reach a revised size of US$ 2411 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Short-acting Nicotine Replacement Therapy (NRT) refers to fast-acting products that deliver nicotine quickly to help manage sudden cravings and withdrawal symptoms during smoking cessation. These include nicotine gum, lozenges, nasal sprays, and oral inhalers, which allow users to control their nicotine intake in real time. Unlike long-acting options like nicotine patches, short-acting NRT provides rapid relief and can be used as needed, making it effective for managing acute urges and improving quit success when combined with behavioral support.
North American market for Short Acting Nicotine Replacement Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Short Acting Nicotine Replacement Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Short Acting Nicotine Replacement Therapy in Online Sales is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Short Acting Nicotine Replacement Therapy include Nicorette (Johnson & Johnson), Dr. Reddy's Laboratories, Equate (Walmart), Swedish Match, NiQuitin (Perrigo), Altria, Philip Morris, Alkalon, LUCY GOODS, Nicotex (Cipla Health), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Short Acting Nicotine Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Acting Nicotine Replacement Therapy.
The Short Acting Nicotine Replacement Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Acting Nicotine Replacement Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Short Acting Nicotine Replacement Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nicorette (Johnson & Johnson)
Dr. Reddy's Laboratories
Equate (Walmart)
Swedish Match
NiQuitin (Perrigo)
Altria
Philip Morris
Alkalon
LUCY GOODS
Nicotex (Cipla Health)
Japan Tobacco International (JTI)
British American Tobacco (BAT)
Skruf Snus
Segment by Type
Nicotine Gum
Nicotine Lozenge
Nasal Spray
Oral Inhaler
Nicotine Pouches
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Short Acting Nicotine Replacement Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nicotine Gum
1.2.3 Nicotine Lozenge
1.2.4 Nasal Spray
1.2.5 Oral Inhaler
1.2.6 Nicotine Pouches
1.3 Market by Application
1.3.1 Global Short Acting Nicotine Replacement Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Short Acting Nicotine Replacement Therapy Market Perspective (2020-2031)
2.2 Global Short Acting Nicotine Replacement Therapy Growth Trends by Region
2.2.1 Global Short Acting Nicotine Replacement Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Short Acting Nicotine Replacement Therapy Historic Market Size by Region (2020-2025)
2.2.3 Short Acting Nicotine Replacement Therapy Forecasted Market Size by Region (2026-2031)
2.3 Short Acting Nicotine Replacement Therapy Market Dynamics
2.3.1 Short Acting Nicotine Replacement Therapy Industry Trends
2.3.2 Short Acting Nicotine Replacement Therapy Market Drivers
2.3.3 Short Acting Nicotine Replacement Therapy Market Challenges
2.3.4 Short Acting Nicotine Replacement Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Short Acting Nicotine Replacement Therapy Players by Revenue
3.1.1 Global Top Short Acting Nicotine Replacement Therapy Players by Revenue (2020-2025)
3.1.2 Global Short Acting Nicotine Replacement Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Short Acting Nicotine Replacement Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Short Acting Nicotine Replacement Therapy Revenue
3.4 Global Short Acting Nicotine Replacement Therapy Market Concentration Ratio
3.4.1 Global Short Acting Nicotine Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Acting Nicotine Replacement Therapy Revenue in 2024
3.5 Global Key Players of Short Acting Nicotine Replacement Therapy Head office and Area Served
3.6 Global Key Players of Short Acting Nicotine Replacement Therapy, Product and Application
3.7 Global Key Players of Short Acting Nicotine Replacement Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Short Acting Nicotine Replacement Therapy Breakdown Data by Type
4.1 Global Short Acting Nicotine Replacement Therapy Historic Market Size by Type (2020-2025)
4.2 Global Short Acting Nicotine Replacement Therapy Forecasted Market Size by Type (2026-2031)
5 Short Acting Nicotine Replacement Therapy Breakdown Data by Application
5.1 Global Short Acting Nicotine Replacement Therapy Historic Market Size by Application (2020-2025)
5.2 Global Short Acting Nicotine Replacement Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Short Acting Nicotine Replacement Therapy Market Size (2020-2031)
6.2 North America Short Acting Nicotine Replacement Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025)
6.4 North America Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Short Acting Nicotine Replacement Therapy Market Size (2020-2031)
7.2 Europe Short Acting Nicotine Replacement Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025)
7.4 Europe Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size (2020-2031)
8.2 Asia-Pacific Short Acting Nicotine Replacement Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Short Acting Nicotine Replacement Therapy Market Size (2020-2031)
9.2 Latin America Short Acting Nicotine Replacement Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025)
9.4 Latin America Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size (2020-2031)
10.2 Middle East & Africa Short Acting Nicotine Replacement Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nicorette (Johnson & Johnson)
11.1.1 Nicorette (Johnson & Johnson) Company Details
11.1.2 Nicorette (Johnson & Johnson) Business Overview
11.1.3 Nicorette (Johnson & Johnson) Short Acting Nicotine Replacement Therapy Introduction
11.1.4 Nicorette (Johnson & Johnson) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.1.5 Nicorette (Johnson & Johnson) Recent Development
11.2 Dr. Reddy's Laboratories
11.2.1 Dr. Reddy's Laboratories Company Details
11.2.2 Dr. Reddy's Laboratories Business Overview
11.2.3 Dr. Reddy's Laboratories Short Acting Nicotine Replacement Therapy Introduction
11.2.4 Dr. Reddy's Laboratories Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.2.5 Dr. Reddy's Laboratories Recent Development
11.3 Equate (Walmart)
11.3.1 Equate (Walmart) Company Details
11.3.2 Equate (Walmart) Business Overview
11.3.3 Equate (Walmart) Short Acting Nicotine Replacement Therapy Introduction
11.3.4 Equate (Walmart) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.3.5 Equate (Walmart) Recent Development
11.4 Swedish Match
11.4.1 Swedish Match Company Details
11.4.2 Swedish Match Business Overview
11.4.3 Swedish Match Short Acting Nicotine Replacement Therapy Introduction
11.4.4 Swedish Match Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.4.5 Swedish Match Recent Development
11.5 NiQuitin (Perrigo)
11.5.1 NiQuitin (Perrigo) Company Details
11.5.2 NiQuitin (Perrigo) Business Overview
11.5.3 NiQuitin (Perrigo) Short Acting Nicotine Replacement Therapy Introduction
11.5.4 NiQuitin (Perrigo) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.5.5 NiQuitin (Perrigo) Recent Development
11.6 Altria
11.6.1 Altria Company Details
11.6.2 Altria Business Overview
11.6.3 Altria Short Acting Nicotine Replacement Therapy Introduction
11.6.4 Altria Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.6.5 Altria Recent Development
11.7 Philip Morris
11.7.1 Philip Morris Company Details
11.7.2 Philip Morris Business Overview
11.7.3 Philip Morris Short Acting Nicotine Replacement Therapy Introduction
11.7.4 Philip Morris Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.7.5 Philip Morris Recent Development
11.8 Alkalon
11.8.1 Alkalon Company Details
11.8.2 Alkalon Business Overview
11.8.3 Alkalon Short Acting Nicotine Replacement Therapy Introduction
11.8.4 Alkalon Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.8.5 Alkalon Recent Development
11.9 LUCY GOODS
11.9.1 LUCY GOODS Company Details
11.9.2 LUCY GOODS Business Overview
11.9.3 LUCY GOODS Short Acting Nicotine Replacement Therapy Introduction
11.9.4 LUCY GOODS Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.9.5 LUCY GOODS Recent Development
11.10 Nicotex (Cipla Health)
11.10.1 Nicotex (Cipla Health) Company Details
11.10.2 Nicotex (Cipla Health) Business Overview
11.10.3 Nicotex (Cipla Health) Short Acting Nicotine Replacement Therapy Introduction
11.10.4 Nicotex (Cipla Health) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.10.5 Nicotex (Cipla Health) Recent Development
11.11 Japan Tobacco International (JTI)
11.11.1 Japan Tobacco International (JTI) Company Details
11.11.2 Japan Tobacco International (JTI) Business Overview
11.11.3 Japan Tobacco International (JTI) Short Acting Nicotine Replacement Therapy Introduction
11.11.4 Japan Tobacco International (JTI) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.11.5 Japan Tobacco International (JTI) Recent Development
11.12 British American Tobacco (BAT)
11.12.1 British American Tobacco (BAT) Company Details
11.12.2 British American Tobacco (BAT) Business Overview
11.12.3 British American Tobacco (BAT) Short Acting Nicotine Replacement Therapy Introduction
11.12.4 British American Tobacco (BAT) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.12.5 British American Tobacco (BAT) Recent Development
11.13 Skruf Snus
11.13.1 Skruf Snus Company Details
11.13.2 Skruf Snus Business Overview
11.13.3 Skruf Snus Short Acting Nicotine Replacement Therapy Introduction
11.13.4 Skruf Snus Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025)
11.13.5 Skruf Snus Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nicotine Gum
Table 3. Key Players of Nicotine Lozenge
Table 4. Key Players of Nasal Spray
Table 5. Key Players of Oral Inhaler
Table 6. Key Players of Nicotine Pouches
Table 7. Global Short Acting Nicotine Replacement Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Short Acting Nicotine Replacement Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Short Acting Nicotine Replacement Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Short Acting Nicotine Replacement Therapy Market Share by Region (2020-2025)
Table 11. Global Short Acting Nicotine Replacement Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Short Acting Nicotine Replacement Therapy Market Share by Region (2026-2031)
Table 13. Short Acting Nicotine Replacement Therapy Market Trends
Table 14. Short Acting Nicotine Replacement Therapy Market Drivers
Table 15. Short Acting Nicotine Replacement Therapy Market Challenges
Table 16. Short Acting Nicotine Replacement Therapy Market Restraints
Table 17. Global Short Acting Nicotine Replacement Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Short Acting Nicotine Replacement Therapy Market Share by Players (2020-2025)
Table 19. Global Top Short Acting Nicotine Replacement Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Acting Nicotine Replacement Therapy as of 2024)
Table 20. Ranking of Global Top Short Acting Nicotine Replacement Therapy Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Short Acting Nicotine Replacement Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Short Acting Nicotine Replacement Therapy, Headquarters and Area Served
Table 23. Global Key Players of Short Acting Nicotine Replacement Therapy, Product and Application
Table 24. Global Key Players of Short Acting Nicotine Replacement Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Short Acting Nicotine Replacement Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Short Acting Nicotine Replacement Therapy Revenue Market Share by Type (2020-2025)
Table 28. Global Short Acting Nicotine Replacement Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Short Acting Nicotine Replacement Therapy Revenue Market Share by Type (2026-2031)
Table 30. Global Short Acting Nicotine Replacement Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Short Acting Nicotine Replacement Therapy Revenue Market Share by Application (2020-2025)
Table 32. Global Short Acting Nicotine Replacement Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Short Acting Nicotine Replacement Therapy Revenue Market Share by Application (2026-2031)
Table 34. North America Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 49. Nicorette (Johnson & Johnson) Company Details
Table 50. Nicorette (Johnson & Johnson) Business Overview
Table 51. Nicorette (Johnson & Johnson) Short Acting Nicotine Replacement Therapy Product
Table 52. Nicorette (Johnson & Johnson) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 53. Nicorette (Johnson & Johnson) Recent Development
Table 54. Dr. Reddy's Laboratories Company Details
Table 55. Dr. Reddy's Laboratories Business Overview
Table 56. Dr. Reddy's Laboratories Short Acting Nicotine Replacement Therapy Product
Table 57. Dr. Reddy's Laboratories Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 58. Dr. Reddy's Laboratories Recent Development
Table 59. Equate (Walmart) Company Details
Table 60. Equate (Walmart) Business Overview
Table 61. Equate (Walmart) Short Acting Nicotine Replacement Therapy Product
Table 62. Equate (Walmart) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 63. Equate (Walmart) Recent Development
Table 64. Swedish Match Company Details
Table 65. Swedish Match Business Overview
Table 66. Swedish Match Short Acting Nicotine Replacement Therapy Product
Table 67. Swedish Match Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 68. Swedish Match Recent Development
Table 69. NiQuitin (Perrigo) Company Details
Table 70. NiQuitin (Perrigo) Business Overview
Table 71. NiQuitin (Perrigo) Short Acting Nicotine Replacement Therapy Product
Table 72. NiQuitin (Perrigo) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 73. NiQuitin (Perrigo) Recent Development
Table 74. Altria Company Details
Table 75. Altria Business Overview
Table 76. Altria Short Acting Nicotine Replacement Therapy Product
Table 77. Altria Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 78. Altria Recent Development
Table 79. Philip Morris Company Details
Table 80. Philip Morris Business Overview
Table 81. Philip Morris Short Acting Nicotine Replacement Therapy Product
Table 82. Philip Morris Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 83. Philip Morris Recent Development
Table 84. Alkalon Company Details
Table 85. Alkalon Business Overview
Table 86. Alkalon Short Acting Nicotine Replacement Therapy Product
Table 87. Alkalon Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 88. Alkalon Recent Development
Table 89. LUCY GOODS Company Details
Table 90. LUCY GOODS Business Overview
Table 91. LUCY GOODS Short Acting Nicotine Replacement Therapy Product
Table 92. LUCY GOODS Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 93. LUCY GOODS Recent Development
Table 94. Nicotex (Cipla Health) Company Details
Table 95. Nicotex (Cipla Health) Business Overview
Table 96. Nicotex (Cipla Health) Short Acting Nicotine Replacement Therapy Product
Table 97. Nicotex (Cipla Health) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 98. Nicotex (Cipla Health) Recent Development
Table 99. Japan Tobacco International (JTI) Company Details
Table 100. Japan Tobacco International (JTI) Business Overview
Table 101. Japan Tobacco International (JTI) Short Acting Nicotine Replacement Therapy Product
Table 102. Japan Tobacco International (JTI) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 103. Japan Tobacco International (JTI) Recent Development
Table 104. British American Tobacco (BAT) Company Details
Table 105. British American Tobacco (BAT) Business Overview
Table 106. British American Tobacco (BAT) Short Acting Nicotine Replacement Therapy Product
Table 107. British American Tobacco (BAT) Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 108. British American Tobacco (BAT) Recent Development
Table 109. Skruf Snus Company Details
Table 110. Skruf Snus Business Overview
Table 111. Skruf Snus Short Acting Nicotine Replacement Therapy Product
Table 112. Skruf Snus Revenue in Short Acting Nicotine Replacement Therapy Business (2020-2025) & (US$ Million)
Table 113. Skruf Snus Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 117. Authors List of This Report
List of Figures
Figure 1. Short Acting Nicotine Replacement Therapy Picture
Figure 2. Global Short Acting Nicotine Replacement Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Short Acting Nicotine Replacement Therapy Market Share by Type: 2024 VS 2031
Figure 4. Nicotine Gum Features
Figure 5. Nicotine Lozenge Features
Figure 6. Nasal Spray Features
Figure 7. Oral Inhaler Features
Figure 8. Nicotine Pouches Features
Figure 9. Global Short Acting Nicotine Replacement Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Short Acting Nicotine Replacement Therapy Market Share by Application: 2024 VS 2031
Figure 11. Online Sales Case Studies
Figure 12. Offline Sales Case Studies
Figure 13. Short Acting Nicotine Replacement Therapy Report Years Considered
Figure 14. Global Short Acting Nicotine Replacement Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Short Acting Nicotine Replacement Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Short Acting Nicotine Replacement Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Short Acting Nicotine Replacement Therapy Market Share by Players in 2024
Figure 18. Global Short Acting Nicotine Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Short Acting Nicotine Replacement Therapy Revenue in 2024
Figure 20. North America Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Short Acting Nicotine Replacement Therapy Market Share by Country (2020-2031)
Figure 22. United States Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Short Acting Nicotine Replacement Therapy Market Share by Country (2020-2031)
Figure 26. Germany Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Short Acting Nicotine Replacement Therapy Market Share by Region (2020-2031)
Figure 34. China Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Short Acting Nicotine Replacement Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Short Acting Nicotine Replacement Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Short Acting Nicotine Replacement Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Nicorette (Johnson & Johnson) Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 50. Dr. Reddy's Laboratories Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 51. Equate (Walmart) Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 52. Swedish Match Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 53. NiQuitin (Perrigo) Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 54. Altria Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 55. Philip Morris Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 56. Alkalon Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 57. LUCY GOODS Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 58. Nicotex (Cipla Health) Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 59. Japan Tobacco International (JTI) Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 60. British American Tobacco (BAT) Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 61. Skruf Snus Revenue Growth Rate in Short Acting Nicotine Replacement Therapy Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Retail Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
